Cryosa Completes $8.25 Million in Series A-2 Funding for Further Development of Breakthrough, Minimally Invasive Treatment for Obstructive Sleep Apnea View more
Maintaining Engagement: The Role of Virtual Communication During and After the COVID-19 Crisis View more
